Cancer second largest killer in India: Oncology report

There were 1.17 million new cancer cases in India whereas 6,75,000 deaths in 2013

cancer

Cancer kills the most number of people in India after heart disease, says Global Burden of Cancer report 2013 published by JAMA Oncology.

According to the report, there were 1.17 million new cancer cases in India whereas 6,75,000 deaths in 2013. There is a sharp increase from the figures from 1990 when the numbers registered were 6,24,000 cancer cases and 4,26,000 deaths. Late diagnosis of cancer in advanced stages leads to late treatment, causing more deaths in India.

In 2013 there were 14.9 million incident cancer cases, 8.2 million deaths, and 196.3 million DALYs. Prostate cancer was the leading cause for cancer incidence (1.4 million) for men and breast cancer for women (1.8 million). Tracheal, bronchus, and lung (TBL) cancer was the leading cause for cancer death in men and women, with 1.6 million deaths. For men, TBL cancer was the leading cause of DALYs (24.9 million). For women, breast cancer was the leading cause of DALYs (13.1 million). Age-standardized incidence rates (ASIRs) per 100 000 and age-standardized death rates (ASDRs) per 100 000 for both sexes in 2013 were higher in developing vs developed countries for stomach cancer (ASIR, 17 vs 14; ASDR, 15 vs 11), liver cancer (ASIR, 15 vs 7; ASDR, 16 vs 7), esophageal cancer (ASIR, 9 vs 4; ASDR, 9 vs 4), cervical cancer (ASIR, 8 vs 5; ASDR, 4 vs 2), lip and oral cavity cancer (ASIR, 7 vs 6; ASDR, 2 vs 2), and nasopharyngeal cancer (ASIR, 1.5 vs 0.4; ASDR, 1.2 vs 0.3). Between 1990 and 2013, ASIRs for all cancers combined (except nonmelanoma skin cancer and Kaposi sarcoma) increased by more than 10% in 113 countries and decreased by more than 10% in 12 of 188 countries.

Cancer poses a major threat to public health worldwide, and incidence rates have increased in most countries since 1990. The trend is a particular threat to developing nations with health systems that are ill-equipped to deal with complex and expensive cancer treatments, says report.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

Research Unveiled: Pigmentary Skin Disorders & Premature Hair Greying Most

Wednesday, 18 Jan 2017   |   L’Oréal India Pvt. Ltd.

Business Wire IndiaResearch conducted by recipients of the IADVL-L’Oréal Indian Skin & Hair research

BusinessWire India.com - Pharmaceutical

Bwi-logo

Takeda Recognized as One of the Global 100 Most Sustainable Corporations

Friday, 20 Jan 2017   |   Takeda Pharmaceutical Company Limited

Business Wire India Takeda Pharmaceutical Company Limited [TOKYO:4502], (“Takeda”) is proud to be

Takeda Commences Cash Tender Offer for All Outstanding Shares of ARIAD

Friday, 20 Jan 2017   |   Takeda Pharmaceutical Company Limited

Business Wire India Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) announced the commencement

'The Pediatric Network' Launches TPN Mobile App

Friday, 20 Jan 2017   |   The Pediatric Network

Business Wire IndiaThe Pediatric Network is an alternate child health support program, aimed to simplify

BusinessWire India.com - Medical Devices

Bwi-logo

InFo 124M – Swiss Made EDOF IOL for Cataract Surgery

Friday, 20 Jan 2017   |   SAV-IOL SA

Business Wire India The company Swiss Advanced Vision (SAV-IOL SA - www.sav-iol.com) continues to expand

Bioventus Selects MEDSERVICE to Distribute DUROLANE® in Russia

Wednesday, 18 Jan 2017   |   Bioventus

Business Wire India Bioventus, a leader in orthobiologic solutions, announced it has selected MEDSERVICE

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X